Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,839 | 110,068 | 92,616 | 96,672 | 97,980 |
| Marketable Securities | 40,564 | 39,210 | 127,526 | N/A | N/A |
| Receivables | 180,643 | 193,222 | 194,887 | 268,241 | 183,283 |
| Inventories | 50,561 | 74,629 | 82,700 | 108,908 | 102,510 |
| Income taxes - deferred | 1,257 | 14,455 | 14,630 | 14,094 | 7,696 |
| Other current assets | 3,559 | 9,810 | 28,173 | 12,134 | 16,208 |
| TOTAL | $352,792 | $460,593 | $553,629 | $511,618 | $416,528 |
| Non-Current Assets | |||||
| PPE Net | 58,869 | 53,326 | 51,482 | 225,855 | 221,595 |
| Investments And Advances | 15,409 | 15,337 | N/A | N/A | N/A |
| Intangibles | 545,771 | 568,580 | 617,264 | 427,514 | 636,154 |
| Other Non-Current Assets | 41,764 | 45,341 | 24,979 | 122,939 | 188,907 |
| TOTAL | $661,813 | $682,584 | $693,725 | $776,308 | $1,046,656 |
| Total Assets | $1,014,605 | $1,143,177 | $1,247,354 | $1,287,926 | $1,463,184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 35,152 | N/A | 10,810 | 405,367 | 51,158 |
| Accounts payable and accrued liabilities | 30,252 | 20,874 | 32,027 | 63,571 | 42,363 |
| Other current liabilities | 29,641 | 39,755 | 22,854 | 17,713 | 36,080 |
| TOTAL | $261,011 | $313,938 | $310,959 | $610,421 | $222,527 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 31,641 | 28,480 | N/A | 285,802 |
| Other Non-Current Liabilities | 371,861 | 332,698 | 261,158 | 116,334 | 159,620 |
| TOTAL | $383,311 | $375,051 | $302,035 | $120,385 | $469,078 |
| Total Liabilities | $644,322 | $688,989 | $612,994 | $730,806 | $691,605 |
| Shareholders' Equity | |||||
| Common Shares | 1,225,979 | 1,224,224 | 1,233,692 | 1,238,537 | 1,238,537 |
| Retained earnings | -1,040,982 | -944,003 | -769,770 | -822,406 | -559,063 |
| Other shareholders' equity | 185,286 | 173,967 | 170,438 | 148,642 | 88,883 |
| TOTAL | $370,283 | $454,188 | $634,360 | $564,773 | $768,357 |
| Total Liabilities And Equity | $1,014,605 | $1,143,177 | $1,247,354 | $1,295,579 | $1,459,962 |